Bristol Myers Squibbs

Question 1

Nivolumab (Opdivo)

Answer 1

This is a drug used to treat metastatic melanoma. The mechanism of action is by binding to the PD-1 receptor.

Question 2

Abecma

Answer 2

This is a BCMA CAR T Cell Therapy for patients with multiple myeloma.

Question 3

Ipilimumab (Yervoy)

Answer 3

This is a monoclonal antibody that activates the immune system by targeting CTLA-4, a protein receptor that downregulates the immune system.